Entries by Maren Kühr

Austria – magnet for biotechnology

The life sciences location of Austria has gained considerable momentum since the ­founding of the very first Austrian biotech company Intercell at the turn of the millennium. Today the who’s who of the biotech sector relies on Austria, in particular on its capital city of Vienna.

The Next Big Thing: “Biologisation”

The development of a sustainable bio-based economy will lead to disruptive economic changes. Venture capitalists focused on targets to drive digitisation in the past are now moving their attention to the bioeconomy

The Next Big Thing: "Biologisation"

The development of a sustainable bio-based economy will lead to disruptive economic changes. Venture capitalists focused on targets to drive digitisation in the past are now moving their attention to the bioeconomy

New CEO for Galapagos

Co-founder and former board member of Galapagos NV Dr Paul Stoffels will take over the position of Chief Executive Officer at the Belgian company from April. He succeeds long-time CEO Onno van de Stolpe, who is retiring.

Immunovia with acting CEO

Immunovia AB announces that Philipp Mathieu has been appointed as acting CEO and President with immediate effect. The search for a permanent CEO continues, as previously communicated.